Menu

Odyssey Therapeutics, Inc. ODTX

Full chart Compare
Set alert

Price alert · ODTX

All alert types
19.23 USD +0.35 (+1.85%)

At closeNov 9, 2026, 7:07 AM EST

18.60 -0.63 -3.25%

Pre-market · Nov 9, 7:07 AM ET

18.01 Day range 19.70
15.10 52-week range 29.05
YTD
+17.11%
1 year
+17.11%

Revenue & Expenses

Other Income → Expenses: $11.60MIncome Tax Benefit → Expenses: $927.00KExpenses → Selling, General & Admin: $37.52MExpenses → Research & Development: $126.62MExpenses → Interest Expense: $17.00KGross Profit → Expenses: $2.98MRevenue → Gross Profit: $2.98MNet Loss → Expenses: $148.65MOther Income$11.60MIncome Tax Benefit$927.00KGross Profit$2.98MNet Loss$148.65MExpenses$164.15MSelling, General & Admin$37.52MResearch & Development$126.62MInterest Expense$17.00KRevenue$2.98M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

ODTX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
2.98M4.47M
2.98M4.47M
2.98M4.47M
164.13M139.69M
126.62M112.58M
37.52M27.12M
-161.16M-135.22M
17.00K18.00K
-927.00K469.00K
-148.65M-130.40M
-148.65M-130.40M
-148.65M-130.40M
-148.65M-129.32M
-48.93-148.21
-48.93-148.21
-48.93-148.21
-149.56M-129.91M
-149.56M-129.91M
3.04M879.83K
3.04M879.83K